nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allogeneic hematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sézary syndrome: 2023 update of the Milan experience
|
Onida, Francesco |
|
|
190 |
S1 |
p. |
artikel |
2 |
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
|
De Masson, Adele |
|
|
190 |
S1 |
p. |
artikel |
3 |
Analysis of clonal immunoglobulin chain gene rearrangement by the technique of polymerase chain reaction (PCR) to aid in the diagnosis of B-cell cutaneous lymphoproliferative processes
|
Guimaraes, Adriana Borba |
|
|
190 |
S1 |
p. |
artikel |
4 |
Annual Meeting
|
|
|
|
190 |
S1 |
p. |
artikel |
5 |
Annual Meeting Sponsor Page
|
|
|
|
190 |
S1 |
p. |
artikel |
6 |
A novel inducible knockout mouse strain to study the impact of one-copy loss of HNRNPK in CD4 T cells as an experimental model of cutaneous lymphoma
|
Luo, Yixin |
|
|
190 |
S1 |
p. |
artikel |
7 |
An overview of the epidemiology and therapeutical modalities in 426 patients with mycosis fungoides and folliculotropic mycosis fungoides in the Netherlands: a retrospective cohort study
|
Kersten, Juliette |
|
|
190 |
S1 |
p. |
artikel |
8 |
Anti-PD-L1 and lenalidomide enhance anti-tumor immunity in cutaneous T cell lymphoma through targeting PD1+M2-like tumor-associated macrophages
|
Querfeld, Christiane |
|
|
190 |
S1 |
p. |
artikel |
9 |
A real-world international observational study of mogamulizumab in adult patients with mycosis fungoides and Sézary syndrome (PROSPER study NCT05455931)
|
Scarisbrick, Julia |
|
|
190 |
S1 |
p. |
artikel |
10 |
Author Index
|
|
|
|
190 |
S1 |
p. |
artikel |
11 |
Black patients with cutaneous T-cell lymphomas have inferior outcomes: an analysis of the National Cancer Database from 2004–2019
|
Allen, Pamela |
|
|
190 |
S1 |
p. |
artikel |
12 |
Blood tumour burden does not correlate with skin tumour burden in early-stage mycosis fungoides (MF): PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) registry analysis
|
Charalambides, Maria |
|
|
190 |
S1 |
p. |
artikel |
13 |
Brentuximab vedotin as a bridging treatment for mycosis fungoides prior to reduced intensity allogeneic stem cell transplant
|
Sim, Van |
|
|
190 |
S1 |
p. |
artikel |
14 |
Capturing the patient’s voice in cutaneous lymphoma
|
Lawrance, Nicholas |
|
|
190 |
S1 |
p. |
artikel |
15 |
CCR8 expression as a potential diagnostic and therapeutic biomarker in cutaneous T-cell lymphoma
|
Geller, Shamir |
|
|
190 |
S1 |
p. |
artikel |
16 |
CD8 positive Sézary syndrome: two cases
|
Peterknecht, Elizabeth |
|
|
190 |
S1 |
p. |
artikel |
17 |
CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas
|
Ta, Van Anh |
|
|
190 |
S1 |
p. |
artikel |
18 |
Characterization of skin barrier function and ceramide composition in patients with mycosis fungoides
|
Mergen, Catherine |
|
|
190 |
S1 |
p. |
artikel |
19 |
Chlormethine gel as first-line and as maintenance treatment in MF stages IA–IIB
|
Koumourtzis, Marios |
|
|
190 |
S1 |
p. |
artikel |
20 |
Chlormethine gel as maintenance treatment for patients with mycosis fungoides
|
Geskin, Larisa |
|
|
190 |
S1 |
p. |
artikel |
21 |
Chlormethine gel in combination with retinoids for treatment of mycosis fungoides
|
Teoli, Miriam |
|
|
190 |
S1 |
p. |
artikel |
22 |
Chlormethine gel is an effective “add-on” agent for the treatment of skin lesions in patients with mycosis fungoides in clinical practice
|
Morsia, Erika |
|
|
190 |
S1 |
p. |
artikel |
23 |
Clinical presentation and treatment outcome in two patients with intravascular large B cell lymphoma
|
Osmancevic, Amra |
|
|
190 |
S1 |
p. |
artikel |
24 |
Clinicopathological definition, management and prognostic value of mogamulizumab-associated rash and other cutaneous events: a systematic review
|
Roccuzzo, Gabriele |
|
|
190 |
S1 |
p. |
artikel |
25 |
Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1+ epithelial-type γδT cells
|
Nakagawa, Yuki |
|
|
190 |
S1 |
p. |
artikel |
26 |
Combination of JAKi and HDACi as a potential anti-angiogenic treatment in a cutaneous T-cell lymphoma (CTCL) in vivo chick embryo model
|
Karagianni, Fani |
|
|
190 |
S1 |
p. |
artikel |
27 |
Concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam therapy in 14 patients with tumor stage mycosis fungoides
|
Oymanns, Mathias |
|
|
190 |
S1 |
p. |
artikel |
28 |
Concurrent TSEBT and systemic therapies in advanced CTCL: our practical approach in Krefeld, Germany
|
Oymanns, Mathias |
|
|
190 |
S1 |
p. |
artikel |
29 |
Copyright Page
|
|
|
|
190 |
S1 |
p. |
artikel |
30 |
Cutaneous lymphoproliferations after mRNA vaccination: a clinicopathologic characterization
|
Kempf, Werner |
|
|
190 |
S1 |
p. |
artikel |
31 |
Cutaneous manifestation of mature plasmacytoid dendritic cell proliferation in patients with myeloid leukemia
|
Hillen, Uwe |
|
|
190 |
S1 |
p. |
artikel |
32 |
Cutaneous manifestations of lymphoid‐variant hypereosinophilic syndrome
|
Laurent, Claire |
|
|
190 |
S1 |
p. |
artikel |
33 |
Cutaneous relapses location in diffuse large B-cell lymphoma leg type after immunochemotherapy
|
Pham-Ledard, Anne |
|
|
190 |
S1 |
p. |
artikel |
34 |
Depicting a network of PKCθ effectors and their roles in the biology of CTCL cells
|
Merino, Maria |
|
|
190 |
S1 |
p. |
artikel |
35 |
Detection of circulating tumor DNA in liquid biopsies of patients with primary cutaneous diffuse large B-cell lymphoma, leg type
|
Schrader, Anne |
|
|
190 |
S1 |
p. |
artikel |
36 |
Diagnostic and prognostic significance of bone marrow biopsies for cutaneous T-cell lymphoma
|
Weiner, David |
|
|
190 |
S1 |
p. |
artikel |
37 |
Diagnostic outcomes and treatment modalities in patients with mycosis fungoides in west Sweden: a retrospective register-based study
|
Wojewoda, Karolina |
|
|
190 |
S1 |
p. |
artikel |
38 |
Differentiating lymphocytic hypereosinophilic syndrome from Sézary syndrome using transcriptomic analysis
|
Pierog, Olivia |
|
|
190 |
S1 |
p. |
artikel |
39 |
Editorial Board
|
|
|
|
190 |
S1 |
p. |
artikel |
40 |
Efficacy and safety of methotrexate in the treatment of mycosis fungoides: results from a multicenter study
|
Panou, Evdoxia |
|
|
190 |
S1 |
p. |
artikel |
41 |
Efficacy and tolerability of mogamulizumab in patients with mycosis fungoides or Sézary syndrome: retrospective and real-world data from centres of the French Study Group of Cutaneous Lymphoma
|
Beylot-Barry, Marie |
|
|
190 |
S1 |
p. |
artikel |
42 |
Elucidating genetic factors of cutaneous T-cell lymphoma staging and disease severity through machine learning
|
Schreidah, Celine M. |
|
|
190 |
S1 |
p. |
artikel |
43 |
Epidemiology of cutaneous T-cell lymphomas in Italy: data analysis from the Marche multidisciplinary team (MDT) register and Italian Cutaneous Lymphoma Study Group (ICLSG) open study
|
Morsia, Erika |
|
|
190 |
S1 |
p. |
artikel |
44 |
Evaluating the impact of a novel multidisciplinary mycosis fungoides cutaneous T-cell lymphoma clinic day on patient care
|
Heath, Harry |
|
|
190 |
S1 |
p. |
artikel |
45 |
Examining the long-term effects of educational intervention on illness perception in cutaneous T-cell lymphoma patients: a comparative analysis of gender, race, and age subgroups
|
Munjal, Ananya |
|
|
190 |
S1 |
p. |
artikel |
46 |
Ex vivo harmonic generation microscopy assessment in cutaneous T-cell lymphomas diagnosis
|
Pavlova, Olesya |
|
|
190 |
S1 |
p. |
artikel |
47 |
Genomic abnormalities involving class I HLA are common in advanced cutaneous T-cell lymphoma
|
Kwang, Alexa |
|
|
190 |
S1 |
p. |
artikel |
48 |
Genomic profiling of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder and angioimmunoblastic T-cell lymphoma
|
Rodríguez, Marta |
|
|
190 |
S1 |
p. |
artikel |
49 |
Haemophagocytic lymphohistiocytosis in a patient with stage IVA2 Sézary syndrome
|
Thomas, Bjorn |
|
|
190 |
S1 |
p. |
artikel |
50 |
Health-related quality of life assessed over time in the PROCLIPI study
|
Molloy, Kevin |
|
|
190 |
S1 |
p. |
artikel |
51 |
Health-related quality of life (HRQL) in cutaneous T-cell lymphoma: burden of disease and patient characteristics from a post-hoc analysis of a phase 3 trial in mycosis fungoides and Sézary syndrome
|
Romero, Pablo |
|
|
190 |
S1 |
p. |
artikel |
52 |
HLA I shields tumor lymphocytes from NK cell-mediated elimination in the skin
|
Chang, Yun-Tsan |
|
|
190 |
S1 |
p. |
artikel |
53 |
Immune cell profiling and regulatory proteins in MF lesions
|
Vetsika, Eleni-Kyriaki |
|
|
190 |
S1 |
p. |
artikel |
54 |
Inhibition of XPO1 with Selinexor (KPT-330) triggers apoptosis in cutaneous T-cell lymphoma (CTCL) by activating the p53-p21 and p27 pathways
|
Chakravarti, Nitin |
|
|
190 |
S1 |
p. |
artikel |
55 |
Insights from the 2020 Lymphoma Coalition Global Patient Survey on Lymphomas and CLL: the burden of fatigue
|
Beatty, Paula |
|
|
190 |
S1 |
p. |
artikel |
56 |
Interstitial fluid immunophenotyping of early-stage mycosis fungoides patients after chlormethine treatment
|
Wind, Selinde |
|
|
190 |
S1 |
p. |
artikel |
57 |
ISCL/USCLC/EORTC guidelines for the diagnosis, staging, and treatment of pediatric mycosis fungoides
|
Hodak, Emilia |
|
|
190 |
S1 |
p. |
artikel |
58 |
Is there microbial dysbiosis in CTCL? A pilot study
|
Peterknecht, Elizabeth |
|
|
190 |
S1 |
p. |
artikel |
59 |
KIR3DL2 also represents a novel therapeutic target in non-cutaneous aggressive systemic peripheral T-cell lymphomas
|
Ortonne, Nicolas |
|
|
190 |
S1 |
p. |
artikel |
60 |
Lacutamab in patients with mycosis fungoides: efficacy results according to updated lymph node classification in the TELLOMAK study
|
Bagot, Martine |
|
|
190 |
S1 |
p. |
artikel |
61 |
Leveraging deep learning to resolve skin lymphoma characteristics through highly multiplexed protein fluorescent imaging
|
Prompsy, Pacome |
|
|
190 |
S1 |
p. |
artikel |
62 |
Liquid biopsy assessment in primary cutaneous diffuse large B-Cell lymphoma- leg type
|
Pham-Ledard, Anne |
|
|
190 |
S1 |
p. |
artikel |
63 |
Lymphomatoid papulosis in paediatric population: results of a multicentre retrospective cohort study
|
Blanchard, Maël |
|
|
190 |
S1 |
p. |
artikel |
64 |
Modulation of immune cell polarization and PD-L1 expression by MF fibroblast exosomes: potential implications for immunotherapy in MF
|
Moyal, Lilach |
|
|
190 |
S1 |
p. |
artikel |
65 |
Mogamulizumab-induced colitis
|
Blanchard, Maël |
|
|
190 |
S1 |
p. |
artikel |
66 |
Mogamulizumab in patients with mycosis fungoides or Sézary syndrome: interim analysis of the German non-interventional MINT study
|
Assaf, Chalid |
|
|
190 |
S1 |
p. |
artikel |
67 |
Molecular identity revealed by NanoString analysis between tumoral erythroderma and inflammatory erythroderma
|
Rodríguez, Marta |
|
|
190 |
S1 |
p. |
artikel |
68 |
Multimodal therapy with bexarotene and extracorporeal photopheresis for T-cell cutaneous lymphomas: real-life experiences in Argentina
|
Baquero Rey, Jenny Andrea |
|
|
190 |
S1 |
p. |
artikel |
69 |
Multi-omics cytokine screening reveals immunosuppressive microenvironment in cutaneous T-cell lymphoma
|
Tsai, Yi-Chien |
|
|
190 |
S1 |
p. |
artikel |
70 |
Non-invasive digital disease severity scoring compared to CAILS in early-stage mycosis fungoides
|
Wind, Selinde |
|
|
190 |
S1 |
p. |
artikel |
71 |
Non-myeloablative allogeneic stem cell transplantation using TSEBT, TLI and ATG for mycosis fungoides and Sézary syndrome: results from a large single centre cohort
|
Thomas, Bjorn |
|
|
190 |
S1 |
p. |
artikel |
72 |
Oncogenic drivers in NF-kappaB pathway-related elements provide candidate targets for future targeted therapies in Sézary syndrome
|
Espinosa, Lluís |
|
|
190 |
S1 |
p. |
artikel |
73 |
One-year assessment of consultations at the Dutch national referral and expertise center for cutaneous lymphomas
|
Doeleman, Thom |
|
|
190 |
S1 |
p. |
artikel |
74 |
Primary anaplastic large cell lymphoma in children and adolescents: case reports and literature review
|
Barzilai, Aviv |
|
|
190 |
S1 |
p. |
artikel |
75 |
Primary cutaneous CD4-positive small/medium pleomorphic lymphoproliferative disease: a retrospective analysis of 15 patients
|
Patel, Nikesh |
|
|
190 |
S1 |
p. |
artikel |
76 |
Primary cutaneous epidermotropic, cytotoxic, ALK+ T-cell lymphoma: observation of a novel case and review of the literature point at a discrete pattern of disease, with response to target therapy
|
Croci, Giorgio Alberto |
|
|
190 |
S1 |
p. |
artikel |
77 |
Primary cutaneous follicle center lymphoma with secondary systemic evolution
|
Li, Andy |
|
|
190 |
S1 |
p. |
artikel |
78 |
Prognostic factors in mycosis fungoides and Sézary syndrome: results from the PROCLIPI study
|
Scarisbrick, Julia |
|
|
190 |
S1 |
p. |
artikel |
79 |
Progressive peripheral polyneuropathy in a patient with Sézary syndrome
|
Pappa, Vasiliki |
|
|
190 |
S1 |
p. |
artikel |
80 |
Quality of life in cutaneous lymphoma varies by lymphoma type
|
Lawrance, Nicholas |
|
|
190 |
S1 |
p. |
artikel |
81 |
Racial disparities in mycosis fungoides/Sézary syndrome: an observational study of 296 patients
|
Myskowski, Patricia |
|
|
190 |
S1 |
p. |
artikel |
82 |
Real-world effectiveness of mogamulizumab in patients with Sézary syndrome or mycosis fungoides in Spain and Portugal: The MIBERIC study
|
Romero, Pablo Ortiz |
|
|
190 |
S1 |
p. |
artikel |
83 |
Real world evidence: assessing the clinical efficacy of mogamulizumab in mycosis fungoides and Sézary syndrome using time to next treatment
|
Scarisbrick, Julia |
|
|
190 |
S1 |
p. |
artikel |
84 |
Real-world outcomes and tolerability of mogamulizumab monotherapy and multimodality therapy for cutaneous T-cell lymphoma: results from a multicenter retrospective cohort study
|
Weiner, David |
|
|
190 |
S1 |
p. |
artikel |
85 |
RESMAIN: results of a multicenter, randomized, double blind, placebocontrolled trial to evaluate resminostat for maintenance treatment in advanced stage mycosis fungoides or Sézary syndrome
|
Stadler, Rudolf |
|
|
190 |
S1 |
p. |
artikel |
86 |
Re-treatment approaches in patients with cutaneous-T-cell lymphoma: a real-life experience
|
Roccuzzo, Gabriele |
|
|
190 |
S1 |
p. |
artikel |
87 |
Role of total skin electron beam radiotherapy at relapse after allogeneic transplant in mycosis fungoides and Sézary syndrome
|
Simontacchi, Gabriele |
|
|
190 |
S1 |
p. |
artikel |
88 |
Sensitivity to brentuximab vedotin depends on CD30-expression levels in different subtypes of cutaneous T-cell lymphoma cell lines
|
Hofer, Vivian |
|
|
190 |
S1 |
p. |
artikel |
89 |
Single-cell RNA sequencing characterization of primary cutaneous B-cell lymphomas with their systemic counterparts
|
Griss, Johanns |
|
|
190 |
S1 |
p. |
artikel |
90 |
Single-cell RNA sequencing reveals crosstalk between T cells and endothelial cells in intravascular T-cell lymphoma
|
Traidl, Stephan |
|
|
190 |
S1 |
p. |
artikel |
91 |
Single-cell spatial immune landscapes of cutaneous T cell lymphomas (CTCL)
|
Merkus, Veerle |
|
|
190 |
S1 |
p. |
artikel |
92 |
Single-center experience with superficial radiation therapy of cutaneous lymphomas
|
Szakonyi, Jozsef Agoston |
|
|
190 |
S1 |
p. |
artikel |
93 |
Skin infiltrating NK cells in cutaneous T-cell lymphoma are increased in number and display phenotypic alterations partially driven by the tumor
|
Brauner, Hanna |
|
|
190 |
S1 |
p. |
artikel |
94 |
Skin involvement in systemic lymphoma of follicular helper T-cell origin: a cohort study of 57 patients
|
Stammler, Romain |
|
|
190 |
S1 |
p. |
artikel |
95 |
SNP rs10748643 within the promoter region of ENTPD1 (the gene encoding CD39) has no prognostic value in Sézary patients
|
Luo, Yixin |
|
|
190 |
S1 |
p. |
artikel |
96 |
Standard brentuximab vedotin schedule vs early discontinuation on clinician’s decision in patients with CTCL: a multicenter, retrospective study from the FIL Cutaneous Lymphomas Task Force
|
Grandi, Vieri |
|
|
190 |
S1 |
p. |
artikel |
97 |
Sustained complete remission in Sézary syndrome using extracorporeal photopheresis: a multicentric case series
|
Cankaya, Rohat |
|
|
190 |
S1 |
p. |
artikel |
98 |
Table of Contents
|
|
|
|
190 |
S1 |
p. |
artikel |
99 |
T cell receptor beta constant 1 as a potential marker to better assess T cell clonality in skin samples
|
Iselin, Christoph |
|
|
190 |
S1 |
p. |
artikel |
100 |
T-cell receptor clonality analyses using nanopore sequencing for cutaneous T-cell lymphoma
|
Cieslak, Cassandra |
|
|
190 |
S1 |
p. |
artikel |
101 |
Technical alignment of standardized flow cytometry procedures among Cutaneous Lymphoma Working Groups (CLWGs) and EuroFlow centers: update on a Multicenter Study
|
de Bie, Fenna |
|
|
190 |
S1 |
p. |
artikel |
102 |
The impact of advanced-stage cutaneous T-cell lymphoma on quality of life: a qualitative study
|
Ottevanger, Rosanne |
|
|
190 |
S1 |
p. |
artikel |
103 |
The impact of COVID-19 on anxiety, depression, and delays in care for patients with mycosis fungoides
|
Munjal, Ananya |
|
|
190 |
S1 |
p. |
artikel |
104 |
The overlap of skin and blood T-cell clones in early-stage mycosis fungoides
|
Nikabakht, Neda |
|
|
190 |
S1 |
p. |
artikel |
105 |
The spectrum of angioimmunoblastic T-cell lymphoma cutaneous lesions: clinical, pathological and molecular analysis
|
De La Pinta, Francisco Javier Diaz |
|
|
190 |
S1 |
p. |
artikel |
106 |
The validation of T-cell receptor constant beta-1 chain (TRBC1) in cutaneous T-cell lymphoma
|
Pierog, Olivia |
|
|
190 |
S1 |
p. |
artikel |
107 |
The value of digital PCR-based quantification of DNA methylation biomarkers in diagnostic challenging early Sézary syndrome patients
|
Zoutman, Willem |
|
|
190 |
S1 |
p. |
artikel |
108 |
Time to next treatment in primary cutaneous B cell lymphoma: experience on 98 patients
|
Cankaya, Rohat |
|
|
190 |
S1 |
p. |
artikel |
109 |
Title page
|
|
|
|
190 |
S1 |
p. |
artikel |
110 |
Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome
|
Lazaridou, Ingrid |
|
|
190 |
S1 |
p. |
artikel |
111 |
Translational data from a multicenter phase II study on dimethyl fumarate treatment in relapsed and refractory cutaneous T cell lymphoma
|
Melchers, Susanne |
|
|
190 |
S1 |
p. |
artikel |
112 |
Treatment of refractory cutaneous B-cell lymphoid hyperplasia with intralesional rituximab
|
Laube, Simone |
|
|
190 |
S1 |
p. |
artikel |
113 |
Treatment of relapsed/refractory, and advanced stage of mycosis fungoides with brentuximab vedotin (BV): an experience from Kuwait
|
Hamed, Rasha |
|
|
190 |
S1 |
p. |
artikel |
114 |
Treatment trends in CTCL: an update from a tertiary referral center in Italy
|
Roccuzzo, Gabriele |
|
|
190 |
S1 |
p. |
artikel |
115 |
Tumor necrosis factor receptor type 2 (TNFR2) may represent an alternative therapeutic target in Sézary syndrome and mycosis fungoides
|
Beldi-Ferchiou, Asma |
|
|
190 |
S1 |
p. |
artikel |
116 |
Utility of T-cell immunosequencing in distinguishing mycosis fungoides progression from treatment related cutaneous adverse events
|
Nikabakht, Neda |
|
|
190 |
S1 |
p. |
artikel |
117 |
What we have learnt about the treatment of advanced stage MF from the PROCLIPI study
|
Kim, Youn H. |
|
|
190 |
S1 |
p. |
artikel |
118 |
Which parameters to use in flow cytometry in the diagnosis and follow up of mycosis fungoides and Sézary syndrome: a prospective study
|
Kleiner, Pit Leonard |
|
|
190 |
S1 |
p. |
artikel |